Guide

Fatigue on a GLP-1: The Three Explanations Worth Separating

Fatigue is commonly reported during titration and usually settles. Three explanations account for most of it — reduced calorie intake, dehydration from gastrointestinal e

Why the cause matters

Fatigue is a symptom with many possible drivers, and the useful question is not whether the drug causes it but which mechanism is operating in your case. Three account for most reports, and each points somewhere different.

1. Reduced intake

The intended effect is a reduced desire to eat. Where that reduces intake substantially and quickly, tiredness is an ordinary physiological consequence rather than a mysterious side effect.

This is the most common explanation and the most modifiable. It is also the one where the answer is nutritional rather than pharmacological, which is why programmes that supply medication without dietetic input handle it badly.

2. Dehydration

Nausea, vomiting and diarrhoea all reduce fluid intake or increase losses, and mild dehydration presents as fatigue long before it presents as thirst. In SURMOUNT-1 at 15 mg, diarrhoea was reported by 23% of participants and vomiting by 13%.

This one matters clinically beyond how it feels. Dehydration affects kidney function, and the labels for these drugs note acute kidney injury reported in the context of gastrointestinal adverse reactions with volume depletion. Fatigue accompanied by reduced urine output or dizziness on standing is not something to wait out.

3. Rapid weight loss

Losing weight quickly is metabolically demanding regardless of method, and fatigue accompanies it in bariatric surgery patients and in dieting populations with no medication involved.

Where this is the driver, the modifiable factor is the rate, which is a conversation about dose and titration speed rather than about stopping.

What else to rule out

Fatigue is not specific, and a few things worth checking are unrelated to the drug but common in this population.

• Iron deficiency, particularly where intake has fallen.
• Thyroid function, which affects both weight and energy.
• Sleep apnoea, which is common with obesity and now has its own approved GLP-1 indication. Fatigue is its cardinal symptom, and it may have been present before treatment.
• Other medications, particularly any adjusted alongside weight loss — blood pressure and diabetes medications frequently need review as weight falls.

That last point is worth emphasising. Doses of other drugs calibrated to a higher body weight can become excessive as weight falls, and the symptom that follows is often fatigue.

When to seek help promptly

Fatigue with dizziness on standing, reduced urine output, confusion, or inability to keep fluids down. Those suggest volume depletion rather than tiredness, and the labels flag kidney injury in that context.

Fatigue that worsens rather than settling after a dose has been held for several weeks also warrants review rather than persistence.

The pattern that is reassuring

Fatigue appearing in the days after a dose increase, settling before the next dose, improving as you hold at a dose, and accompanied by no other concerning features. That is the pattern most people describe and it generally resolves as tolerance develops.

Questions readers actually ask